Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
A case of esophageal granular cell tumor diagnosed by mucosal incision-assisted biopsy
Yasuhiro Inokuchi1, Mamoru Watanabe2, Kei Hayashi2
1Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan. inokuchiy@kcch.jp.
Insights
Diagnosing esophageal granular cell tumors (GCTs) requires adequate tissue. Mucosal incision-assisted biopsy (MIAB) provides a simple method to obtain sufficient specimens when other techniques fail.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Pathology
Background:
- Esophageal submucosal masses require definitive diagnosis, often via immunohistochemistry.
- Granular cell tumors (GCTs) are a type of esophageal submucosal mass.
- Accurate diagnosis of GCTs depends on obtaining sufficient biopsy material.
Observation:
- Forceps biopsy and endoscopic ultrasound-fine needle aspiration (EUS-FNA) can yield insufficient tissue samples for GCT diagnosis.
- EUS-FNA may present challenges in acquiring adequate tumor material.
- Mucosal incision-assisted biopsy (MIAB) is a technique for collecting larger biopsy specimens.
Findings:
- MIAB is a straightforward method to obtain larger tissue samples compared to forceps biopsy or EUS-FNA.
- The presented case successfully diagnosed an esophageal GCT using MIAB.
- MIAB addresses the challenge of inadequate specimen yield in diagnosing esophageal GCTs.
Implications:
- MIAB can improve diagnostic yield for esophageal submucosal masses suspicious for GCT.
- This technique offers a valuable alternative for obtaining adequate biopsy material when standard methods are insufficient.
- Successful MIAB facilitates timely and accurate diagnosis and subsequent management of esophageal GCTs.
Abstract:
For an esophageal submucosal mass suspicious of granular cell tumor (GCT) based on gross appearance and endoscopic ultrasound findings, a sufficient number of biopsy specimens is required for a definite diagnosis using immunohistochemical examination. When the specimen obtained by forceps biopsy is insufficient, endoscopic ultrasound-fine needle aspiration (EUS-FNA) is believed to be an useful alternative. However, it may be difficult to obtain an adequate amount of tumor material using EUS-FNA. Mucosal incision-assisted biopsy (MIAB) is a simple method that can collect larger amounts of specimens. This procedure is helpful for physicians who encounter the problem of obtaining an adequate amount of biopsy material from esophageal tumors suspicious for GCT. We present a case of esophageal GCT that was successfully diagnosed through MIAB.
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

